NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/17/2020
Back to search
Official data from USPTO
RENCELL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
01/17/2020
Trademark type
Word
Nice classes
1, 5
Filing date
04/02/2007
Registration date
03/16/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/17/2020
Last transaction
01/17/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Pencoed, Brigend, GB
Examiner
BENJAMIN, SARA NICOLE
Law office
M10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ReNeuron Limited
ReNeuron Limited
Representatives
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cells for scientificlaboratory and medical research; human cells for scientificlaboratory and medical research; stem cells for scientificlaboratory and medical research; encapsulated cells for scientificlaboratory and medical research; encapsulated cell aggregates for scientificlaboratory and medical research; microcapsules and macrocapsules containing cells or cell aggregates for scientificlaboratory and medical research
Class 5
Cells for medical or clinical use; human cells for medical or clinical use; stem cells for medical or clinical use; encapsulated cells for medical or clinical use; encapsulated cell aggregates for medical or clinical use; encapsulated cells for use in cell-based medical therapies; microcapsules and macrocapsules containing cells or cell aggregates for medical or clinical use
Publications
History of USPTO decisions and trademark events.
52 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/17/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/17/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
01/14/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
11/18/2016
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/18/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/18/2016
E815
TEAS SECTION 8 & 15 RECEIVED
09/09/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
03/16/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/29/2009
PUBO
PUBLISHED FOR OPPOSITION
12/29/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/24/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/05/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
11/04/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/03/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
11/03/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/03/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/09/2009
GNRT
NON-FINAL ACTION E-MAILED
10/09/2009
CNRT
NON-FINAL ACTION WRITTEN
10/09/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/17/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/17/2009
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/17/2009
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
04/30/2009
GNSI
INQUIRY TO SUSPENSION E-MAILED
04/30/2009
CNSI
SUSPENSION INQUIRY WRITTEN
04/30/2009
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/30/2009
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/30/2008
GNSL
LETTER OF SUSPENSION E-MAILED
10/30/2008
CNSL
SUSPENSION LETTER WRITTEN
10/30/2008
DMCC
DATA MODIFICATION COMPLETED
10/29/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2008
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/07/2008
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
07/07/2008
GNSI
INQUIRY TO SUSPENSION E-MAILED
07/07/2008
CNSI
SUSPENSION INQUIRY WRITTEN
07/07/2008
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/02/2008
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/02/2008
GNSL
LETTER OF SUSPENSION E-MAILED
01/02/2008
CNSL
SUSPENSION LETTER WRITTEN
01/02/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/10/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/10/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/10/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/17/2007
GNRT
NON-FINAL ACTION E-MAILED
07/17/2007
CNRT
NON-FINAL ACTION WRITTEN
07/17/2007
DOCK
ASSIGNED TO EXAMINER
07/16/2007
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/16/2007
ALIE
ASSIGNED TO LIE
05/16/2007
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
04/24/2007
NWAP
NEW APPLICATION ENTERED
04/05/2007
Continuous trademark protection
Get notified about every new filing that threatens RENCELL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.